Neural Organoids

NeuraCell’s neural organoids provide researchers with high-fidelity, human-relevant 3D brain models derived from induced pluripotent stem cells (iPSCs). Designed to recapitulate region-specific tissue architecture and multicellular interactions, these organoids offer powerful platforms for neuroscience, drug discovery, and disease modeling.

We routinely produce forebrain, midbrain, and custom-patterned organoids from well-characterized wild-type iPSC donors. In addition, NeuraCell offers exclusive access to more than 100 genetically defined lines—including MAPT-mutant and matched isogenic controls from the Tau Consortium iPSC Collection—enabling rigorous genotype–phenotype studies and translational neurodegeneration research. Researchers may also submit their own iPSC lines for bespoke organoid generation.

Organoids can be ordered at defined maturation stages (2, 4, and 6 months) and are available as live cultures or snap-frozen samples. To support robust, reproducible science, we encourage incorporating organoids from multiple donor backgrounds.

Contact us for current inventory, custom options, and pricing details.

  • Cortical Brain Organoid

    Forebrain Cortical Organoids

    By modeling the complexity of the human cortex, forebrain cortical organoids enable researchers to evaluate neurotoxicity, target engagement, and mechanisms of action—offering translational insights that bridge the gap between cell-based assays and clinical research.

  • Midbrain Cortical Organoids

    Midbrain Cortical Organoids

    Human midbrain cortical organoids enable researchers to assess dopaminergic neuron vulnerability, neurotoxicity, target engagement, and mechanisms of action—providing translational insights that more accurately bridge preclinical models with clinical research in neurodegenerative disease.

  • neural organoids red green

    Neural Spheroids

    Neural spheroids enable researchers to evaluate cell–cell interactions, microenvironmental responses, viability, and drug-induced toxicity within a controlled 3D system—providing translational bridge between traditional 2D cell-based assays and more complex organoid or in vivo models.

  • Striatal Cortical Organoids

    Striatal Cortical Organoids

    Human striatal cortical organoids enable researchers to evaluate medium spiny neuron vulnerability, neurotoxicity, target engagement, and mechanisms of action—providing translational insights that bridge the gap between simplified cell-based assays and clinically relevant models of basal ganglia disorders.